Clinical Trials Browser

Phase NA × INDUSTRY × Lymphoma, Non-Hodgkin × Clear all

NCT03229876 2023-07-24

Safety and Efficacy Evaluation of CD19-UCART

Phase NA Suspended

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05206071 2022-01-25

Clinical Study of SL19+22 CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma

Phase NA Unknown

Lymphoma, Non-Hodgkin

NCT04666168 2020-12-14

A Multicenter Clinical Study on the Safety and Efficacy of CAR-T in the Treatment of Relapsed / Refractory Non Hodgkin's Lymphoma

Phase NA Unknown

Lymphoma, Non-Hodgkin

NCT04447547 2020-09-29

Clinical Trial of SL1904B CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma

Phase NA Unknown

Lymphoma, Non-Hodgkin

NCT04497688 2020-08-04

Evaluate the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia After Chemotherapy in Patients With Non-Hodgkin's Lymphoma

Phase NA Unknown

Lymphoma, Non-Hodgkin

NCT04237428 2020-01-23

CD19-CART in the Treatment of R/R CD19 Positive Non-Hodgkin's Lymphoma

Phase NA Unknown

Lymphoma, Non-Hodgkin

NCT00002284 2005-06-24

A Study of Azidothymidine (AZT) in the Treatment of HIV Infection in Patients Receiving a Bone Marrow Transplant

Phase NA Completed

LymphoidSarcoma

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Lymphoma, Non-Hodgkin, HIV Infections, Dendritic Cell Sarcoma, Interdigitating

NCT00022958 2005-06-24

Expanded Access Study of Iodine-131 Anti-B1 Antibody

Phase NA Unknown

Lymphoma, Non-Hodgkin